Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

162.18USD
31 Oct 2014
Price Change (% chg)

$0.60 (+0.37%)
Prev Close
$161.58
Open
$164.56
Day's High
$164.65
Day's Low
$161.42
Volume
7,973,043
Avg. Vol
3,892,304
52-wk High
$164.65
52-wk Low
$108.20

AMGN.O

Chart for AMGN.O

About

Amgen Inc. is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics. Its medicines help millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis (RA), bone disease, and other serious illnesses. On December 10, 2012, the Company acquired all of the... (more)

Overall

Beta: 0.52
Market Cap (Mil.): $123,365.50
Shares Outstanding (Mil.): 760.67
Dividend: 0.61
Yield (%): 1.50

Financials

  AMGN.O Industry Sector
P/E (TTM): 25.52 32.70 33.67
EPS (TTM): 6.35 -- --
ROI: 8.54 18.12 17.39
ROE: 20.76 18.79 18.21
Search Stocks

US STOCKS-Wall St jumps 1 pct, S&P ends above key level

* Indexes up: Dow 1.1 pct, S&P 1.2 pct, Nasdaq 1.8 pct (Updates to close, adds Facebook results after the close)

28 Oct 2014

US STOCKS-Wall St gains as earnings, confidence data beat expectations

* Indexes up: Dow 0.6 pct, S&P 0.7 pct, Nasdaq 1.3 pct (Updates to afternoon trading)

28 Oct 2014

Amgen 2015 outlook tops estimates, no plan to split; shares jump

NEW YORK - Amgen Inc , which has come under investor pressure to split the company, said Tuesday it has no plans to do so and forecast 2015 earnings and revenue well ahead of analysts' projections, sending shares up 5 percent.

28 Oct 2014

UPDATE 3-Amgen 2015 outlook tops estimates, no plan to split; shares jump

NEW YORK, Oct 28 - Amgen Inc, which has come under investor pressure to split the company, said Tuesday it has no plans to do so and forecast 2015 earnings and revenue well ahead of analysts' projections, sending shares up 5 percent.

28 Oct 2014

Amgen 2015 forecast tops Street view; sees cost cuts, share buyback

NEW YORK, Oct 28 - Amgen Inc on Tuesday forecast 2015 earnings and revenue well ahead of Wall Street projections and announced plans to cut costs and increase returns to shareholders through a dividend increase and share repurchases.

28 Oct 2014

Amgen, Sanofi, Ono link with academia on proteins project

LONDON - U.S.-based Amgen, France's Sanofi and Ono Pharmaceutical of Japan have linked with three research institutes to study a super-family of proteins controlling everything from taste to the spread of cancer.

28 Oct 2014

Amgen, Sanofi, Ono link with academia on proteins project

LONDON, Oct 28 - U.S.-based Amgen, France's Sanofi and Ono Pharmaceutical of Japan have linked with three research institutes to study a super-family of proteins controlling everything from taste to the spread of cancer.

28 Oct 2014

Amgen profit tops Wall Street expectations; raises 2014 outlook

- Amgen Inc on Monday reported higher-than-expected third quarter earnings and revenue, even as net profit fell due to a hefty restructuring charge, and the company raised its full-year forecast and the number of job cuts it expects to make.

27 Oct 2014

UPDATE 3-Amgen profit tops Wall Street expectations; raises 2014 outlook

Oct 27 - Amgen Inc on Monday reported higher-than-expected third quarter earnings and revenue, even as net profit fell due to a hefty restructuring charge, and the company raised its full-year forecast and the number of job cuts it expects to make.

27 Oct 2014

BRIEF-Amgen now expects job cuts to exceed 2,900

Oct 27 - Amgen Inc : * Says now expects job cuts to exceed 2,900, up from prior view of 2,400 to

27 Oct 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks